Halozyme Therapeutics Inc (HALO)

[maumar]

It looks like you may be right and so far today we have a rally on strong volume.

And just speculating for fun, I am sticking to the $40 projection by the end of the year I made in May.

maumar Member Level Wednesday, 05/13/20 11:50:48 AM
Re: Fred Kadiddlehopper post# 5932 0
Post # of 5996
All of the above, plus a new deal, 3 phase 3 trial starts, SC Perjeta/Herceptin approval by October, hopefully sooner, and we may see $40 by the end of the year. I think many investors (and analysts) still need to be reassured that this time (with Darzalex and perjeta/herceptin) it will be different.

I am still amazed that our royalties from huge blockbusters like Herceptin and Mabthera peaked at only $20.9M in Q1 18 and came down to $15.8M in Q2 20. I don't know if we will get to $250M per quarter by 2027 but I do think that this time it will be different and I am encouraged by the fact that Helen confirmed the 3 new phase 3 trials in 2020.

https://www.loncarblog.com/halozyme-royalty-revenue